Telix Pharmaceuticals - Telix signs a big China deal
Telix announced on 2 November 2020 that it has entered into a licensing agreement with China Grand Pharmaceutical (CGP) for the greater Chinese...
412 Views
Telix Pharmaceuticals - TLX591-CDx NDA submitted
On 24 September 2020 Telix announced it had submitted its NDA to the FDA for approval of TLX591-CDx, its positron emission tomography (PET) imaging...
176 Views
Telix Pharmaceuticals - A look at future directions
For the first time, Telix provided a profile of its deep pipeline outside its lead asset on its H120 earnings call. It presented the details of...
101 Views
Telix Pharmaceuticals - Major developments coming up
We expect 2020 to be a major turning point for Telix Pharmaceuticals. The regulatory submissions for illumet will determine whether the company...
87 Views
Telix Pharmaceuticals - Making progress despite headwinds
The NDA submission for illumet has been delayed slightly by COVID-19 but is expected to be submitted in Q220 (from March-April guidance). A...
108 Views